Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.

Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.

Tumor necrosis factor-alpha (TNF) has been unequivocally validated as a therapeutic target in a number of immune-mediated inflammatory disorders (IMIDs). There is now increasing choice of biologic agents within the class all of which successfully neutralize sTNF. But approaches to TNF inhibition dif...

Descripció completa

Dades bibliogràfiques
Autor principal:	Taylor, P
Format:	Journal article
Idioma:	English
Publicat:	2010

Ítems similars

Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
per: Taylor, P
Publicat: (2001)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
per: Maini, R, et al.
Publicat: (1997)

The effect of TNF blockade on insulin resistance in patients with rheumatoid arthritis
per: Edwards, C, et al.
Publicat: (2006)

TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
per: Bystrom, J, et al.
Publicat: (2016)

Cytokine blockade in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (2001)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
per: Elliott, M, et al.
Publicat: (1995)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
per: Elliott, M, et al.
Publicat: (1995)

Incomplete response of inflammatory arthritis to TNF alpha blockade is associated with the Th17 pathway
per: Alzabin, S, et al.
Publicat: (2012)

Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway.
per: Alzabin, S, et al.
Publicat: (2012)

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
per: Feldmann, M, et al.
Publicat: (2003)

20th anniversary of TNF inhibitors in rheumatoid arthritis
per: Taylor, P
Publicat: (2019)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
per: Maini, R, et al.
Publicat: (1995)

Effect of TNF-α Blockade in Gingival Crevicular Fluid on Periodontal Condition of Patients with Rheumatoid Arthritis
per: Zeinab Kadkhoda, et al.
Publicat: (2016-09-01)

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
per: Feldman, M, et al.
Publicat: (1998)

Hip arthritis in the TNF-Blockade era: an unresolved issue?
per: Scott C, et al.
Publicat: (2008-09-01)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
per: Davis, D, et al.
Publicat: (1997)

Editorial: combination cytokine blockade: the way forward in therapy for rheumatoid arthritis?
per: Taylor, P, et al.
Publicat: (2015)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
per: Feldmann, M, et al.
Publicat: (2011)

Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance
per: Taylor, PC, et al.
Publicat: (2024)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
per: Taylor, P, et al.
Publicat: (2009)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
per: Maini, R, et al.
Publicat: (1993)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
per: Taylor, P, et al.
Publicat: (2000)

Pro-inflammatory cytokine blockade attenuates myeloid expansion in a murine model of rheumatoid arthritis
per: Giovanny Hernandez, et al.
Publicat: (2020-03-01)

Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis.
per: Bart V J Cuppen, et al.
Publicat: (2016-01-01)

Development of anti-TNF therapy for rheumatoid arthritis.
per: Feldmann, M
Publicat: (2002)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
per: Maini, R, et al.
Publicat: (1994)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
per: Maini, R, et al.
Publicat: (2000)

TNF alpha as a therapeutic target in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1994)

The association of extended TNF haplotypes and susceptibility to rheumatoid arthritis
per: Newton, J, et al.
Publicat: (2001)

TNFα blockers and infectious risk in rheumatoid arthritis
per: S. Todesco, et al.
Publicat: (2011-06-01)

Inflammatory bowel disease and rheumatoid arthritis
per: Zong-Biao TAN, et al.
Publicat: (2022-10-01)

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
per: Feldmann, M, et al.
Publicat: (2003)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
per: E. A. Golikova, et al.
Publicat: (2012-05-01)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1992)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1995)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (2001)

TNFα - A pivotal role in rheumatoid arthritis?
per: Brennan, F, et al.
Publicat: (1992)

TNF alpha--a pivotal role in rheumatoid arthritis?
per: Brennan, F, et al.
Publicat: (1992)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
per: Cynthia Said, et al.
Publicat: (2013-01-01)

The metabolic effects of TNF inhibitors in rheumatoid arthritis patients
per: Alexandra Jitaru, et al.
Publicat: (2019-12-01)